Grant: Discovery Grants Program - Individual
Institut national de la recherche scientifique
$30,000.00
Molecular Mechanisms of Macrophage Translational Regulation by Escherichia coli Lipopolysaccharide
FY 2015-16
Summary
Pathogenic bacteria, including Escherichia coli, express in their surface several toxins. One of them is called lipopolysaccharide (LPS). LPS is one of the most potent activators of a variety of immune cells, including macrophages. During bacterial infections, LPS interacts with proteins expressed in the macrophage surface named receptors. This event triggers a cascade of intracellular signals that lead to the induction of pro-inflammatory and anti-microbial molecules. Their production helps to protect the host against pathogen invasion. However, hyperactivation of the immune system can be detrimental and lead to death by endotoxin shock. Numerous studies have focused on how LPS stimulates transcription (RNA expression) of inflammatory and immune-responsive genes. In addition to transcriptional regulation, activation of RNA translation (protein synthesis) allows the cell to rapidly respond to infectious agents. Even though LPS triggers a robust and quick macrophage response, the contribution of translational control to such activation remains largely unexplored. Therefore, the current research program designed to identify the RNAs associated to inflammation and immunity, which are controlled by LPS at the translational level. We also aim to dissect the intracellular signals involved. To this end we will deploy a combination of biochemical, molecular biology and genetic experimental approaches. The stimulation of macrophage activation by LPS constitutes an excellent model of inflammation and has greatly contributed to understand how the host cell, and ultimately the immune system of patients, responds to infectious agents. Our data will shed light on the importance of translational control in response to bacterial toxins, which will aid the advance of knowledge on the molecular mechanisms that govern host -pathogen interactions. Importantly, our work will contribute to establish whether regulators of translation could become new therapeutic targets for treatments against bacterial infections and thereby improve the life quality of Canadians.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
419469-2012
Name nom
JaramilloPatino, Maritza
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
4
Nb partie
5
Application title
Molecular Mechanisms of Macrophage Translational Regulation by Escherichia coli Lipopolysaccharide
Keyword
NSERC
Application summary
Pathogenic bacteria, including Escherichia coli, express in their surface several toxins. One of them is called lipopolysaccharide (LPS). LPS is one of the most potent activators of a variety of immune cells, including macrophages. During bacterial infections, LPS interacts with proteins expressed in the macrophage surface named receptors. This event triggers a cascade of intracellular signals that lead to the induction of pro-inflammatory and anti-microbial molecules. Their production helps to protect the host against pathogen invasion. However, hyperactivation of the immune system can be detrimental and lead to death by endotoxin shock. Numerous studies have focused on how LPS stimulates transcription (RNA expression) of inflammatory and immune-responsive genes. In addition to transcriptional regulation, activation of RNA translation (protein synthesis) allows the cell to rapidly respond to infectious agents. Even though LPS triggers a robust and quick macrophage response, the contribution of translational control to such activation remains largely unexplored. Therefore, the current research program designed to identify the RNAs associated to inflammation and immunity, which are controlled by LPS at the translational level. We also aim to dissect the intracellular signals involved. To this end we will deploy a combination of biochemical, molecular biology and genetic experimental approaches. The stimulation of macrophage activation by LPS constitutes an excellent model of inflammation and has greatly contributed to understand how the host cell, and ultimately the immune system of patients, responds to infectious agents. Our data will shed light on the importance of translational control in response to bacterial toxins, which will aid the advance of knowledge on the molecular mechanisms that govern host -pathogen interactions. Importantly, our work will contribute to establish whether regulators of translation could become new therapeutic targets for treatments against bacterial infections and thereby improve the life quality of Canadians.